CAP-1002

cardiosphere-derived cells · Capricor Therapeutics

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CAP-1002, covering 2016-06-21 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy [Phase 2]